2019
DOI: 10.1016/j.molmed.2019.01.009
|View full text |Cite
|
Sign up to set email alerts
|

EphrinB2-EphB4-RASA1 Signaling in Human Cerebrovascular Development and Disease

Abstract: Recent whole exome sequencing studies in humans have provided novel insight into the importance of the ephrinB2-EphB4-RASA1 signaling axis in cerebrovascular development, corroborating and extending previous work in model systems. Here, we aim to review the human cerebrovascular phenotypes associated with ephrinB2-EphB4-RASA1 mutations, including those recently discovered in Vein of Galen malformation-the most common and severe brain arteriovenous malformation in neonates. We will also discuss emerging paradig… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
27
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 44 publications
(28 citation statements)
references
References 83 publications
(127 reference statements)
0
27
0
Order By: Relevance
“…RASA1 activates the intrinsic GTPase activity of Ras to promote the hydrolysis of Ras GTP to Ras GDP. RASA1 binds to activated Ras (Ras GTP) via the GTPase activating protein (GAP)-related catalytic domain to block the Ras signaling and inhibit the Ras-MAPK pathway, thereby inhibiting the proliferation but promoting the apoptosis of cells (Zeng 2019 ; Chen et al 2019 ). Hence, we hypothesized that MEG3 activates the Ras-MAPK pathway by negatively regulating the protein levels of RASA1.…”
Section: Discussionmentioning
confidence: 99%
“…RASA1 activates the intrinsic GTPase activity of Ras to promote the hydrolysis of Ras GTP to Ras GDP. RASA1 binds to activated Ras (Ras GTP) via the GTPase activating protein (GAP)-related catalytic domain to block the Ras signaling and inhibit the Ras-MAPK pathway, thereby inhibiting the proliferation but promoting the apoptosis of cells (Zeng 2019 ; Chen et al 2019 ). Hence, we hypothesized that MEG3 activates the Ras-MAPK pathway by negatively regulating the protein levels of RASA1.…”
Section: Discussionmentioning
confidence: 99%
“…Arginine vasopressin receptor 1A (AVPR1A) acts as receptor for arginine vasopressin, which belongs to the subfamily of G-protein coupled receptors [23]. EPH Receptor B4 (EPHB4) mediate numerous developmental processes, particularly in the nervous system [24]. ST3 Beta-Galactoside Alpha-2,3-Sialyltransferase 1 (ST3GAL1) is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates [25].…”
Section: Discussionmentioning
confidence: 99%
“…1,2 Although its pathogenesis is currently unknown, SCFN has been associated to maternal or birth complications, such as perinatal asphyxia, meconium aspiration, hypoxaemia, therapeutic hypothermia, obstetric trauma, preeclampsia and maternal diabetes. 2,3 SCFN is a classical disease of full-term infants; however, atypical cases in premature newborns have been described. Usually develops in the first 6 weeks of life presenting with erythematous to violaceous, indurated nodules or plaques on the cheeks, buttocks, posterior trunk or proximal extremities.…”
Section: Newborn With Purplish Skin Induration Of the Back Answermentioning
confidence: 99%
“…Post‐mortem examination confirmed these findings. Karyotyping and molecular genetic testing for HRAS and RASA1 mutations were negative. Brain AVM is a rare malformation (0.1%) .…”
Section: Answermentioning
confidence: 99%